
Two things can be true at once in today’s screen economy: transgender performers face real, documented risks of bias, and the entire business has been in a jobs recession that has shrunk the casting pie for everyone. The current debate only makes sense if you hold both facts in view and separate what we know from what we feel.
At a Glance
- Anecdotal reports from multiple transgender actors describe abrupt slowdowns in auditions and offers.
- Hollywood has been contracting since the 2023 strikes and the streaming pullback, reducing opportunities across the board.
- Television LGBTQ representation fell alongside overall production; reported drops for trans characters were especially steep.
- Evidence of bias risk exists, but a definitive, disproportionate employment decline for trans actors remains unproven without longitudinal data.
What the actors are saying, and what those stories can and cannot prove
Recent first-person accounts from transgender and gender-diverse performers describe a clear pattern: momentum followed by silence. Actors recount expecting series-regular offers after acclaimed turns; others describe once “booked and busy” calendars going bare; one performer publicly asked for help to qualify for SAG-AFTRA health insurance tied to covered earnings; and a prominent star said casting became “tricky” after transition, with no next project in hand. These are not isolated testimonies; they span different career tiers and formats, from studio films to streaming television.
Those accounts are consequential. They convey lived experience at the point where identity, market demand, and gatekeeping meet. But they are still anecdotes. They do not, on their own, establish that transgender performers’ opportunities have declined more steeply than the market’s overall contraction, or that specific decisions were rooted in anti-trans bias as opposed to shifting slate priorities, role mix, or agency strategy. They are the hypothesis, not yet the dataset.
The market contraction is real and explains a lot, though likely not everything
Any serious analysis starts with the denominator: there are fewer roles. After the 2023 writers’ and actors’ strikes, production did not snap back to the high-water mark of “peak TV” and generous streaming bets. Cost-cutting, slate consolidation, and a reversion to profitability discipline left fewer episodic orders and fewer films in the pipeline. Reporting in 2024–2025 documented a double-digit percentage decline in U.S. production activity relative to the boom period, lagging job recovery, and lower location shoot days—evidence of a thinner labor market for all creatives and crew, including actors.
When the total number of scripted projects contracts, every subgroup of performers feels it. That alone can plausibly produce fewer auditions, fewer callbacks, and challenges meeting health-plan earnings thresholds, without invoking any identity-based cause. This contextual point is not conjecture; it’s borne out by industry tracking and economic reports that put hard numbers to the slowdown.
On-screen representation has fallen with supply; trans-specific roles collapsed faster
Representation metrics show two simultaneous movements. First, LGBTQ characters declined with the overall drop in shows. Second, within that overall decline, several summaries of GLAAD’s television census reported an especially steep fall in transgender characters—falling from several dozen to single digits in the latest cycle. In one roundup, the count moved from 33 trans characters in the prior period to seven out of 369 LGBTQ characters—a stark contraction even after accounting for fewer series ordered and renewed.
What does that mean for working actors? Two things. Actors should in principle be considered for roles irrespective of identity; casting against type or outside biography is normal craft. But when character rosters include fewer explicitly transgender roles, an important lane that reliably hired transgender talent narrows. The supply-side explanation (fewer shows) and the composition shift (fewer trans characters among those shows) together create a tighter funnel for trans actors—whether or not any individual casting decision involved bias.
IS THIS THE END OF TRANSGENDER? 🙏🙏🙏
HOLLYWOOD MOVES AWAY FROM WOKE CASTING AS TRANS REPRESENTATION DISAPPEARS FROM MAJOR FILMS
A new GLAAD report found zero transgender characters across 225 major films released by the industry’s top 10 distributors. Trans actors Elliot Page… pic.twitter.com/tIGklIhzDv
— Melissa Redpill (@MelissaRedpill) November 17, 2026
Bias risk is documented, but attributing today’s bookings gap requires better data
Long before the current contraction, survey research identified material levels of discrimination risk for LGBT performers: reported experiences of disrespect on set, concerns about biased decision-makers, and career fears tied to disclosure. Those findings do not prove discrimination in any single hiring decision, but they establish a risk environment in which identity can affect opportunity, earnings, and treatment.
The present question—have transgender performers suffered a sharper jobs decline than peers because Hollywood “turned its back”?—demands a different standard of proof. It requires longitudinal, role-by-role and audition-by-audition evidence that distinguishes identity effects from macroeconomics. Without that, we are left with a strong suspicion shaped by history and lived experience, set against a market shock that explains quite a lot on its own.
How an expert would test the claim properly
To move this out of the realm of dueling narratives, build a reproducible employment panel. Start with voluntary releases from a stratified sample of transgender actors (and a matched cisgender control group by age, genre, representation tier, and prior credits). Gather agent submissions, audition logs, callbacks, offers, bookings, billing level, episode counts, and covered earnings for several years straddling key breakpoints (e.g., pre- and post-2023 strikes). Link those to project metadata: network/streamer, budget tier, genre, and presence or absence of explicitly trans characters. Then model changes in audition volume, conversion rates, and compensation, controlling for the overall decline in scripted output and shifting series orders. That is the minimal evidentiary bar to credibly isolate identity-linked effects from a contracting market.
In parallel, content analysis can establish whether the sharp reported fall in on-screen transgender characters persists once you normalize for total series volume, and whether it is concentrated by network type, format, or genre. If possible, fold in union health-plan eligibility and residuals trends to capture downstream income effects. None of this requires guessing; it requires rigorous, boring measurement.
Practical implications for studios, casting, and advocates
For studios and streamers, the question is not performative pledges; it is pipeline and accountability. If development slates consistently yield too few parts that trans actors plausibly win—either as trans characters or in roles not defined by gender—then commitments to inclusion are structurally empty. Casting offices can widen nets and push client lists beyond habitual shortlists. Development executives can insist that scripts reflect the societies they purport to portray. None of that violates merit; it simply broadens access to the audition room where merit can be seen.
For advocates and unions, the action item is measurement and member services. Commission the longitudinal study described above with trusted academic partners; expand confidential reporting channels for casting-room conduct; and strengthen pathways to health-plan continuity during systemic downturns. For actors and reps, diversify role targeting and markets where possible—indies, international co-productions, games and performance capture—while preserving leverage for fair consideration on mainstream titles.
The bottom line
The industry is smaller than it was, and that alone has harmed working actors. Within that contraction, transgender performers plausibly face additional headwinds: a steeper drop in trans-character roles and an ambient risk of bias documented in prior surveys. The testimonies now surfacing should be treated as credible signals—serious enough to investigate, not sufficient to convict. If Hollywood wants to know whether it has, in fact, turned its back, it has a straightforward way to find out: count carefully, compare fairly, and let the evidence, not the culture war, decide what needs to change.
Sources:
thegatewaypundit.com, whro.org, gayexpress.co.nz, talkfuse.com












